Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Emerging Technologies & Paradigms for In Vitro Dx Europe 2024

Yoon-Kyoung Cho's Biography

Yoon-Kyoung Cho, Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry

Yoon-Kyoung Cho is a full professor of Biomedical Engineering at UNIST and a group leader in the Center for Soft and Living Matter at the Institute for Basic Science (IBS), Republic of Korea. She is a member of the National Academy of Engineering of Korea (NAEK) and a Fellow of Royal Society of Chemistry (FRSC). She serves as a director at the Chemical and Biological Microsystems Society (CBMS) and an associate editor for Lab on a chip. She received her Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign (UIUC) in 1999, having obtained her M.S. and B.S. in Chemical Engineering from POSTECH in 1994 and 1992, respectively. She worked as a senior researcher (1999–2008) at Samsung Advanced Institute of Technology (SAIT), where she helped create biomedical in vitro diagnostic instruments. Her research spans a broad spectrum from fundamental scientific exploration to translational efforts, focusing primarily on microfluidics and nanomedicine. Her current research topics include a lab-on-a-disc for the detection of rare cells and biomarkers, quantitative analysis of single cells, and system analysis of cellular communication. She published over 135 journal papers and over 205 issued patents, many of which helped Samsung Electronics and two start-ups (Clinomics and LabSpinner) build commercial products. Discover more at

Yoon-Kyoung Cho Image

Lab-on-a-Disc For Precision Medicine

Monday, 18 March 2024 at 17:00

Add to Calendar ▼2024-03-18 17:00:002024-03-18 18:00:00Europe/LondonLab-on-a-Disc For Precision MedicineEmerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The

Liquid biopsy is a promising alternative to tissue biopsy for cancer clinics, as it can provide valuable information on circulating biomarkers and aid in treatment planning for individual patients. However, the process can be expensive, complex, and requires large sample volumes, with low sensitivity being a significant limitation. To address these challenges, we have developed "lab-on-a-disc" systems that utilize centrifugal force to analyze cancer-related biomarkers in biological fluids such as blood or urine. Our system can isolate and detect liquid biopsy markers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs). We have tested our system using clinical samples from cancer patients and are excited to introduce our fluid-assisted separation technology, which allows for fast, uniform, clog-free, and efficient filtration. Additionally, we will discuss our recent studies on the potential of extracellular vesicles (EVs) as cancer biomarkers, which could have significant implications for cancer diagnostics. In addition, we will introduce a hand-powered centrifugal bacterial isolation device to determine the bacterial load and to test antibiotics susceptibility which is designed for the usage in resource-limited settings. We believe that our innovative microfluidic tools can accelerate the translation of liquid biopsy technology into real clinical settings, directly impacting patient care.

Add to Calendar ▼2024-03-18 00:00:002024-03-19 00:00:00Europe/LondonEmerging Technologies and Paradigms for In Vitro Dx Europe 2024Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The